Clinical significance of Sam68 expression in endometrial carcinoma

Tumor Biology

Volumn 36, Issue 6, 2015, Pages 4509-4518

  Wang, Qingying ^a   Li, Yue ^a   Zhou, Jianhong ^a   Liu, Jie ^a   Qin, Jinlong ^a   Xing, Feng ^a   Zhang, Jiawen ^a   Cheng, Jiajing ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Endometrial carcinoma; Proliferation; Sam68; Survival

Indexed keywords

PROTEIN SAM68; SMALL INTERFERING RNA; DNA BINDING PROTEIN; KHDRBS1 PROTEIN, HUMAN; RNA BINDING PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CARCINOMA CELL LINE; CELL PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MIDDLE AGED; MYOMETRIUM; OVERALL SURVIVAL; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; TUMOR INVASION; WESTERN BLOTTING; AGED; BIOSYNTHESIS; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84938972209     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3095-x     Document Type: Article

References (36)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.
2. Baak JP, Snijders W, van Diermen B, van Diest PJ, Diepenhorst FW, Benraadt J. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma. J Clin Oncol. 2003;21:4214–21.
3. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol. 2004;35:649–62.
4. Werner HM, Salvesen HB. Current status of molecular biomarkers in endometrial cancer. Curr Oncol Rep. 2014;16:403.
5. Matias-Guiu X, Davidson B. Prognostic biomarkers in endometrial and ovarian carcinoma. Virchows Arch. 2014;464:315–31.
6. Fumagalli S, Totty NF, Hsuan JJ, Courtneidge SA. A target for src in mitosis. Nature. 1994;368:871–4.
7. Sanchez-Jimenez F, Sanchez-Margalet V. Role of Sam68 in post-transcriptional gene regulation. Int J Mol Sci. 2013;14:23402–19.
8. Bielli P, Busa R, Paronetto MP, Sette C. The RNA-binding protein Sam68 is a multifunctional player in human cancer. Endocr Relat Cancer. 2011;18:R91–102.
9. Najib S, Martin-Romero C, Gonzalez-Yanes C, Sanchez-Margalet V. Role of Sam68 as an adaptor protein in signal transduction. Cell Mol Life Sci. 2005;62:36–43.
10. Bedford MT, Frankel A, Yaffe MB, Clarke S, Leder P, Richard S. Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J Biol Chem. 2000;275:16030–6.
11. Taylor SJ, Shalloway D. An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature. 1994;368:867–71.
12. Taylor SJ, Anafi M, Pawson T, Shalloway D. Functional interaction between c-Src and its mitotic target, Sam 68. J Biol Chem. 1995;270:10120–4.
13. Maa MC, Leu TH, Trandel BJ, Chang JH, Parsons SJ. A protein that is highly related to GTPase-activating protein-associated p62 complexes with phospholipase C gamma. Mol Cell Biol. 1994;14:5466–73.
14. Richard S, Yu D, Blumer KJ, Hausladen D, Olszowy MW, Connelly PA, et al. Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1. Mol Cell Biol. 1995;15:186–97.
15. Espejo A, Cote J, Bednarek A, Richard S, Bedford MT. A protein-domain microarray identifies novel protein–protein interactions. Biochem J. 2002;367:697–702.
16. Trub T, Frantz JD, Miyazaki M, Band H, Shoelson SE. The role of a lymphoid-restricted, Grb2-like SH3–SH2–SH3 protein in T cell receptor signaling. J Biol Chem. 1997;272:894–902.
17. Richard S, Vogel G, Huot ME, Guo T, Muller WJ, Lukong KE. Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis. Oncogene. 2008;27:548–56.
18. Bianchi E, Barbagallo F, Valeri C, Geremia R, Salustri A, De Felici M, et al. Ablation of the Sam68 gene impairs female fertility and gonadotropin-dependent follicle development. Hum Mol Genet. 2010;19:4886–94.
19. Paronetto MP, Messina V, Bianchi E, Barchi M, Vogel G, Moretti C, et al. Sam68 regulates translation of target mRNAs in male germ cells, necessary for mouse spermatogenesis. J Cell Biol. 2009;185:235–49.
20. Song L, Wang L, Li Y, Xiong H, Wu J, Li J, et al. Sam68 up-regulation correlates with, and its down-regulation inhibits, proliferation and tumourigenicity of breast cancer cells. J Pathol. 2010;222:227–37.
21. Busa R, Paronetto MP, Farini D, Pierantozzi E, Botti F, Angelini DF, et al. The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells. Oncogene. 2007;26:4372–82.
22. Classen-Linke I, Kusche M, Knauthe R, Beier HM. Establishment of a human endometrial cell culture system and characterization of its polarized hormone responsive epithelial cells. Cell Tissue Res. 1997;287:171–85.
23. Zhang Z, Li J, Zheng H, Yu C, Chen J, Liu Z, et al. Expression and cytoplasmic localization of Sam68 is a significant and independent prognostic marker for renal cell carcinoma. Cancer Epidemiol Biomark Pre. 2009;18:2685–93.
24. Zhang Z, Xu Y, Sun N, Zhang M, Xie J, Jiang Z. High Sam68 expression predicts poor prognosis in non-small cell lung cancer. Clin Transl Oncol. 2014;16:886–91.
25. Li Z, Yu CP, Zhong Y, Liu TJ, Huang QD, Zhao XH, et al. Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer. Ann Oncol. 2012;23:638–46.
26. Liao WT, Liu JL, Wang ZG, Cui YM, Shi L, Li TT, et al. High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer. BMC Gastroenterol. 2013;13:126.
27. Rajan P, Gaughan L, Dalgliesh C, El-Sherif A, Robson CN, Leung HY, et al. The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor. J Pathol. 2008;215:67–77.
28. Zhao X, Li Z, He B, Liu J, Li S, Zhou L, et al. Sam68 is a novel marker for aggressive neuroblastoma. OncoTargets Ther. 2013;6:1751–60.
29. Liu K, Li L, Nisson PE, Gruber C, Jessee J, Cohen SN. Neoplastic transformation and tumorigenesis associated with Sam68 protein deficiency in cultured murine fibroblasts. J Biol Chem. 2000;275:40195–201.
30. Taylor SJ, Resnick RJ, Shalloway D. Sam68 exerts separable effects on cell cycle progression and apoptosis. BMC Cell Biol. 2004;5:5.
31. Chen ZY, Cai L, Zhu J, Chen M, Chen J, Li ZH, et al. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer. Carcinogenesis. 2011;32:1419–26.
32. Cheng C, Sharp PA. Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Mol Cell Biol. 2006;26:362–70.
33. Cappellari M, Bielli P, Paronetto MP, Ciccosanti F, Fimia GM, Saarikettu J, et al. The transcriptional co-activator snd1 is a novel regulator of alternative splicing in prostate cancer cells. Oncogene. 2014;33:3794–802.
34. Paronetto MP, Cappellari M, Busa R, Pedrotti S, Vitali R, Comstock C, et al. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the rna-binding protein Sam68. Cancer Res. 2010;70:229–39.
35. Valacca C, Bonomi S, Buratti E, Pedrotti S, Baralle FE, Sette C, et al. Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. J Cell Biol. 2010;191:87–99.
36. Modem S, Chinnakannu K, Bai U, Reddy GP, Reddy TR. Hsp22 (HspB8/H11) knockdown induces Sam68 expression and stimulates proliferation of glioblastoma cells. J Cell Physiol. 2011;226:2747–51.